Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Roman-Roman, S
99045  Ergebnisse:
Personensuche X
?
1

Inference on an heteroscedastic Gompertz tumor growth model:

Albano, G. ; Giorno, V. ; Román-Román, P....
Mathematical Biosciences.  328 (2020)  - p. 108428 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Clinical value of R-spondins in triple-negative and metapla..:

Coussy, F ; Lallemand, F ; Vacher, S...
British Journal of Cancer.  116 (2017)  12 - p. 1595-1603 , 2017
Link: https://doi.org/10.1038/..
 
?
3

Cancer-associated SF3B1 mutations affect alternative splici..:

Alsafadi, S. ; Houy, A. ; Battistella, A....
European Journal of Cancer.  61 (2016)  - p. S94-S95 , 2016
Link: https://doi.org/10.1016/..
 
?
4

Assessment of Pi3K and/or MAPK signaling pathway targeting ..:

De Plater, L. ; Deas, O. ; Guibaudet, C....
European Journal of Cancer.  69 (2016)  - p. S130 , 2016
Link: https://doi.org/10.1016/..
 
?
5

Assessment of EGFR-dependent signaling pathway targeting in..:

De Plater, L. ; Deas, O. ; Guibaudet, C....
European Journal of Cancer.  69 (2016)  - p. S130 , 2016
Link: https://doi.org/10.1016/..
 
?
6

UM Cure 2020 − A consortium of European experts in uveal me..:

Dhomen, N. ; Marais, R. ; Jager, M.J....
European Journal of Cancer.  61 (2016)  - p. S204-S205 , 2016
Link: https://doi.org/10.1016/..
 
?
7

Characterization of breast cancer preclinical models reveal..:

Vallerand, D. ; Massonnet, G. ; Kebir, F....
European Journal of Cancer.  69 (2016)  - p. S52-S53 , 2016
Link: https://doi.org/10.1016/..
 
?
8

The MEK1/2 inhibitor selumetinib (AZD6244; ARRY-142886) app..:

Diallo, B. ; Massonnet, G. ; El-Botty, R....
European Journal of Cancer.  69 (2016)  - p. S132 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Preclinical scheduling for metastatic ocular melanoma treat..:

LEMAITRE, S ; NEMATI, F ; THULEAU, A...
Acta Ophthalmologica.  92 (2014)  - p. 0-0 , 2014
Link: https://doi.org/10.1111/..
 
?
10

829 Polo-like Kinase 1 – a Potential Therapeutic Target for..:

Maire, V. ; Némati, F. ; Marty-Prouvost, B....
European Journal of Cancer.  48 (2012)  - p. S199 , 2012
Link: https://doi.org/10.1016/..
 
?
11

524 LRP5: a Potential Therapeutic Target in Triple-negative..:

Maubant, S. ; Maire, V. ; Tesson, B....
European Journal of Cancer.  48 (2012)  - p. 161-162 , 2012
Link: https://doi.org/10.1016/..
 
?
12

576 Integrative Approaches for the Identification of Therap..:

Tesson, B.M. ; Rigaill, G. ; Gentien, D....
European Journal of Cancer.  48 (2012)  - p. S137 , 2012
Link: https://doi.org/10.1016/..
 
?
13

801 ORAL High Throughput Molecular Analyses to Select Patie..:

Arnedos, M. ; De La Cruz, J. ; Job, B....
European Journal of Cancer.  47 (2011)  - p. S95 , 2011
Link: https://doi.org/10.1016/..
 
?
14

183 A DNA signature to identify high-risk small node-negati..:

Gravier, E. ; Pierron, G. ; Vincent-Salomon, A....
European Journal of Cancer Supplements.  8 (2010)  3 - p. 111-112 , 2010
Link: https://doi.org/10.1016/..
 
?
15

Identification of genes regulated during osteoblastic diffe..:

Roman-Roman, S ; Garcia, T ; Jackson, A...
Bone.  32 (2003)  5 - p. 474-482 , 2003
Link: https://doi.org/10.1016/..
 
1-15